Eris Lifesciences Ltd.

NSE: ERIS | BSE: 540596 | ISIN: INE406M01024 | Industry: Pharmaceuticals
| Expensive Rocket
1638.3000 -13.50 (-0.82%)
NSE Jun 06, 2025 15:31 PM
Volume: 55,564
 

1638.30
-0.82%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Eris Lifesciences Ltd. is trading above all available SMAs
More from Eris Lifesciences Ltd.
Recommended